First PROTAC wins FDA approval. This one targets certain metastatic breast cancers.
This is the first of a totally new type of drug that is set to revolutionize drug development.
The story of PROTACs is fascinating and a testament to fundamental research.
It starts with two lines of research including research one why thalidomide causes birth defects the other on how to harness cellular machinery for therapeutics.
1/🧵
https://www.nature.com/articles/d41573-026-00078-6
MCDuncanLab
npub14k…6yep4
2026-05-10 12:27:33 UTC
Author Public Key
npub14k3sv7gtyhujmep00nkx86m4h6yv2rsna740rasupl93h00d2fvq26yep4Seen on
wss://relay.momostr.pinkPublished at
2026-05-10 12:27:33 UTCEvent JSON
{
"id": "4309ae65b084978ca9bc25abbc04264647ece291289b0fb25509c799d395f944",
"pubkey": "ada306790b25f92de42f7cec63eb75be88c50e13efaaf1f61c0fcb1bbded5258",
"created_at": 1778416053,
"kind": 1,
"tags": [
[
"proxy",
"https://mstdn.social/@MCDuncanLab/116550274496671536",
"web"
],
[
"proxy",
"https://mstdn.social/users/MCDuncanLab/statuses/116550274496671536",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://mstdn.social/users/MCDuncanLab/statuses/116550274496671536",
"pink.momostr"
],
[
"-"
]
],
"content": "First PROTAC wins FDA approval. This one targets certain metastatic breast cancers.\n\nThis is the first of a totally new type of drug that is set to revolutionize drug development. \n\nThe story of PROTACs is fascinating and a testament to fundamental research.\n\nIt starts with two lines of research including research one why thalidomide causes birth defects the other on how to harness cellular machinery for therapeutics.\n1/🧵\n\nhttps://www.nature.com/articles/d41573-026-00078-6",
"sig": "32e76a48bef5272320806d413391f2976ce8b636035ab097f64e83384b1814e5e0e05810af0bab3f8f7bd91c524a86aea8fefc6c17ae2a7db4fb001ef973baef"
}